Rezurock® (belumosudil tablets) now listed for public reimbursement, offering access to adult and pediatric patients 12 years and older with chronic GVHD after failure of at least two prior lines of… Read More
Phase 3 AQUILA study showed DARZALEX FASPRO® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring Landmark approval supports earlier intervention… Read More
Fibro dT platform offers a high-capacity solution for mRNA purification with chromatography cycle times under 15 minutes. Sustainable performance, with recovery over 80 percent for many chromatography cycles and across… Read More
KIRKLAND, QC – Merck, known as MSD outside of the United States and Canada, announced that the province of Quebec has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to their… Read More
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular risk – including chronic kidney disease Allschwil, CH – Idorsia… Read More
